Associated vaccine against myxomatosis and HBV (dry) (100 doses) 10 ampoules, 1 ml each

DESCRIPTION

Associated vaccine against myxomatosis and HBV. The vaccine is a pale pink to light brown porous dry mass.

COMPOSITION

From strain B-82 of rabbits myxoma virus and B-87 strain of rabbit hemorrhagic disease virus.

BIOLOGICAL PROPERTIES

The vaccine is harmless to rabbits when administered intramuscularly, subcutaneously or intradermally. The use of the vaccine according to the instructions ensures the formation of intense immunity from the 3rd day after vaccination, for at least 12 months.

INDICATIONS

Prevention of myxomatosis and VGBK in rabbits.

DOSAGE AND APPLICATION

The vaccine is used intramuscularly, subcutaneously, intradermally to immunize healthy rabbits in safe, threatened and unfavorable points for myxomatosis and VGBK. In safe and threatened areas, rabbits are immunized once, starting from 1.5 months of age. Rabbits are vaccinated at any time during pregnancy. Clinically healthy rabbits and young rabbits from 45 days of age are vaccinated at dysfunctional sites for myxomatosis and VGBK. Young animals are revaccinated in 3 months. It is prohibited to vaccinate sick animals. For intramuscular and subcutaneous administration, the vaccine in vials (ampoules) is dissolved per 1 dose of 0.5 cm3 of the solvent and 0.5 cm3 is injected into the thigh area. For intradermal injection, the vaccine in vials (ampoules) is dissolved per 1 dose of 0.2 cm3 of the solvent and 0.2 cm3 is injected into the tail mirror or ear. Before vaccination, syringes and needles are sterilized by boiling for 15-20 minutes. The vaccine injection site is disinfected with 70% alcohol. Each rabbit is inoculated with a separate needle. The vaccinated animal is monitored for 20 days. For intradermal injections, it is recommended to use a needleless injector. Maintenance of the injector is carried out in accordance with the rules set out in the passport. Before starting work, the injector head assembly, plunger, mandrels and spare nozzles are sterilized by boiling in distilled water for 15-20 minutes or treated with 70% alcohol. After assembly, pumping of the injector and 2-3 test 'shots' are carried out in a cotton swab moistened with 70% alcohol. After each injection of the vaccine, the nozzle of the needleless injector is processed by immersing it for 1-3 seconds in 70 percent alcohol.

SIDE EFFECTS

When used according to indications in recommended doses, no side effects have been identified.

SHELF LIFE AND STORAGE

The vaccine is suitable for use within 18 months from the date of manufacture, provided it is stored in a dry and dark place at a temperature of + 2-8 C. Vials (ampoules) with the vaccine containing mold, foreign matter, flakes that did not break when shaken, as well as violation of sealing and integrity is rejected. The discarded dry vaccine, as well as the diluted but unused vaccine within 4 hours, is disinfected by boiling for 20 minutes.

PACKAGING

The vaccine is packaged in 1 ml in sterile ampoules containing 10 immunizing doses. The vials are closed with stoppers and rolled up with aluminum caps, and the ampoules are sealed. Ampoules of 1 ml are packed in a box of 10 pcs. A vaccine instruction manual is included in each box.

Specifications

KolVUP

1

Manufacturer

Pokrovsky plant of biological products

Temperature regime

from +2 to +8

Teaser

against myxomatosis and viral hemorrhagic disease of rabbits